NSE IPO anticipation grows as unlisted shares surge 7% in 6 months; get the latest updates and key insights—read more now!

NSE IPO gathers pace as 20 investors, including Temasek, LIC and SBI, plan to sell around 5 per cent stake via OFS. The issue could raise Rs 22,000–23,000 crore, with the exchange likely to file its ...

The National Stock Exchange of India (NSE) is expected to file its draft red herring prospectus (DRHP) earlier than the initially planned June 14, 2026, deadline, sources reveal.

The Bio Medica Laboratories IPO opened on May 21, with a price band of ₹132- ₹139. The company manufactures pharmaceutical ...

NSE reports strong Q4 profit growth as IPO buzz grows; keep an eye on the anticipated listing and investor eligibility. Learn more about the updates!

India's largest stock exchange is proceeding with its IPO via an offer-for-sale (OFS), allowing eligible existing shareholders to sell their holdings. This move aims to gauge investor interest for a ...

Based on the current unlisted share price of NSE, which can be bought between ₹2,030 and ₹2,045 apiece, the company is valued at around ₹5.06 trillion.

The board has also been strengthened ahead of the listing, with Rajeev Vasudeva appointed as a public interest director and Dinesh Pant joining as a nominee director representing LIC ...

SEBI Chairman Tuhin Kanta Pandey recently said that the regulator is at a very advanced stage of issuing the NOC for the NSE ...

India's largest stock exchange, NSE, is nearing its highly anticipated IPO, with prominent shareholders preparing for a broad ...

NSE, which plans IPO by Q4 FY26, is commanding a total market capitalization close to Rs 5.5-5.7 lakh crore at the current ...